Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (191-200 of 311) with videos related to

Pageof 32
Sort By:
Annals of the Rheumatic Diseases|April 8, 2022
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndromeRaphaele Seror, Gabriel Baron, Marine Camus, et al.
The Lancet. Rheumatology|March 3, 2021
Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesRenaud Felten, Maxime Dubois, Manuel F Ugarte-Gil, et al.
RMD Open|October 25, 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension studyMaya H Buch, Daniel Aletaha, Bernard G Combe, et al.
Arthritis Research & Therapy|July 14, 2021
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in FranceRenaud Felten, Marc Scherlinger, Aurélien Guffroy, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.
Rheumatology (Oxford, England)|May 13, 2021
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Maxime Dubois, Manuel F Ugarte-Gil, et al.
Rheumatology (Oxford, England)|August 2, 2015
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsManuel Ramos-Casals, Pilar Brito-Zerón, Raphaèle Seror, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
JCI Insight|March 9, 2018
Impaired TLR9 responses in B cells from patients with systemic lupus erythematosusVincent Gies, Jean-Nicolas Schickel, Sophie Jung, et al.
The Lancet. Rheumatology|October 13, 2021
Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR RegistryRaphaèle Seror, Marine Camus, Jean-Hugues Salmon, et al.
Pageof 32

Showing results (191-200 of 311) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|April 8, 2022
Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndromeRaphaele Seror, Gabriel Baron, Marine Camus, et al.
The Lancet. Rheumatology|March 3, 2021
Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesRenaud Felten, Maxime Dubois, Manuel F Ugarte-Gil, et al.
RMD Open|October 25, 2024
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension studyMaya H Buch, Daniel Aletaha, Bernard G Combe, et al.
Arthritis Research & Therapy|July 14, 2021
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in FranceRenaud Felten, Marc Scherlinger, Aurélien Guffroy, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.
Rheumatology (Oxford, England)|May 13, 2021
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Maxime Dubois, Manuel F Ugarte-Gil, et al.
Rheumatology (Oxford, England)|August 2, 2015
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsManuel Ramos-Casals, Pilar Brito-Zerón, Raphaèle Seror, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
JCI Insight|March 9, 2018
Impaired TLR9 responses in B cells from patients with systemic lupus erythematosusVincent Gies, Jean-Nicolas Schickel, Sophie Jung, et al.
The Lancet. Rheumatology|October 13, 2021
Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR RegistryRaphaèle Seror, Marine Camus, Jean-Hugues Salmon, et al.
Pageof 32